Top 10 Edits in November 2024
For November 2024, National Government Services, Inc. (NGS) Common Electronic Data Interchange (CEDI) has identified the following top ten edits returned on the 277CA for 5010A1 formatted claims. The edit as returned on the 277CA, the reference and description of the edit are provided below.
5010A1 edits are not specific to the definitions provided. Edit codes received can apply to multiple Edit References. If you received one of the edit codes but the listed explanation does not fit your situation, please review the CMS Edit Spreadsheet on the CEDI website for other possibilities causing your rejection.
Note: Category A3, Status 247 is not a front end rejection. This is stating the rejection is at the line level. Please read further into the 277CA report for subsequent error codes.
CEDI offers a tool to view easy-to-understand descriptions associated with the edit code(s) returned on the 277CA for 5010A1 claims. The tool allows you to enter the Claim Status Category Code (CSCC), the Claim Status Codes (CSCs), and the Entity Identifier Code (EIC) for the edit and returns the possible explanations for the cause of the edit. The 277CA Edit Tool is located on the CEDI website https://www.ngscedi.com under the Self-Service Tools section.
# | Top Ten Edits Received on the 277CA for 5010A1 Claim Files |
---|---|
1 |
CSCC A7: “Acknowledgement /Rejected for Invalid Information…”
Edit Reference: X222.351.2400.SV101-2.020
When the Product or Service ID Qualifier in the 2400.SV101 = "HC", the Procedure Code in the 2400.SV101-2 must be a valid HCPCS Code for the Service Date in the 2400.DTP03 (DTP01 = "472").
The HCPCS can be verified with the PDAC.
This rejection can also be caused by sending an invalid HCPCS and modifier combination. If additional information is needed concerning the validity of the combination, please contact the DME MAC Jurisdiction where the claim will be processed. |
2 |
CSCC A8: “Acknowledgement /Rejected for Invalid Information…”
Edit Reference: X222.087.2010AA.NM109.050
The Billing Provider’s NPI in the 2010AA.NM109 is not associated with the submitter in the 1000A.NM109. Therefore, the Trading Partner/Submitter ID is not authorized to submit claims for the supplier.
If this error is received, the supplier must complete and submit the appropriate form on the CEDI website https://www.ngscedi.com.
Suppliers who use a third party (e.g. a clearinghouse or billing service) must complete the Supplier Authorization Form.
Suppliers who submit their own claims and do not use a third party biller must complete the CMS EDI Enrollment Agreement. |
3 |
CSCC A7: “Acknowledgement /Rejected for Invalid Information…”
Edit Reference: X222.121.2010BA.NM109.020
The subscriber’s Medicare ID number is invalid. Verify the MBI is entered correctly.
The MBI must be 11 positions formatted C A AN N A AN N A A N N, (without spaces) where: "C" is numeric 1-9, "A" is alphabetic characters A-Z (excluding S, L, I, O, B, Z), "N" is numeric 0-9 and "AN" is either alphabetic A-Z (excluding S, L, I, O, B, Z), or numeric 0-9. |
4 |
CSCC A8: “Acknowledgement/Rejected for relational field in error”
Edit Reference: X222.094.2010AA.REF02.050
Billing Provider Tax Identification Number in the 2010AA.REF must be associated with the Billing Provider’s NPI in the 2010AA.NM109.
Verify the information you are submitting matches the information on file with the NPPES and the NPEAST or NPWEST. |
5 |
CSCC A7: “Acknowledgement /Rejected for Invalid Information…”
Edit Reference: X222.351.2400.SV101-3.040
The procedure code modifiers in SV101 must not be duplicated within the same detail service line. |
6 |
CSCC A7: “Acknowledgement /Rejected for Invalid Information…” |
7 |
CSCC A7: “Acknowledgement /Rejected for Invalid Information…” |
8
|
CSCC A7: "Acknowledgement /Rejected for Invalid Information…" |
9 |
CSCC A7: “Acknowledgement /Rejected for Invalid Information…” |
10 |
CSCC A8: “Acknowledgement/Rejected for relational field in error” Edit Reference: X222.423.2410.LIN03.040
This Claim is rejected for relational field Information within the NDC number and HCPCS. For dates of service 10/01/2024 and after, there are new billing instructions for Capecitabine Oral Anticancer Drugs (J8520 and J8521) based on Local Coverage Determination (LCD) L33826. Bill these drugs with HCPCS J8999 (Prescription drug, oral, chemotherapeutic, NOS) until J8522 (Capecitabine (Xeloda) is implemented in the DME MAC systems. HCPCS J8999 must be submitted in the 2400 SV101-2 element. Do NOT submit the NDC in the 2410 LIN03 element, or your claim will be rejected by CEDI. Until further notice, the 2300 NTE Claim narrative must include the drug name (Capecitabine or Xeloda) Dosage, and NDC. |
For more information regarding the front end edits, please send an e-mail to the CEDI Help Desk at ngs.cedihelpdesk@anthem.com.
Post Date: 12/03/2024